{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:34:50Z","timestamp":1787585690368,"version":"build-2736575974"},"reference-count":196,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Phakomatoses encompass a group of rare genetic diseases, such as von Hippel-Lindau syndrome (VHL), neurofibromatosis type 1 (NF1), tuberous sclerosis complex (TSC) and Cowden syndrome (CS). These disorders are due to molecular abnormalities on the RAS-PI3K-Akt-mTOR pathway for NF1, TSC and CS, and to hypoxia sensing for VHL. Phakomatoses share some phenotypic traits such as neurological, ophthalmological and cutaneous features. Patients with these diseases are also predisposed to developing multiple endocrine tissue tumors, e.g., pheochromocytomas\/paragangliomas are frequent in VHL and NF1. All forms of phakomatoses except CS may be associated with digestive neuroendocrine tumors. More rarely, thyroid cancer and pituitary or parathyroid adenomas have been reported. These susceptibilities are noteworthy, because their occurrence rate, prognosis and management differ slightly from the sporadic forms. The aim of this review is to summarize current knowledge on endocrine glands tumors associated with VHL, NF1, TSC, and CS, especially neuroendocrine tumors and pheochromocytomas\/paragangliomas. We particularly detail recent advances concerning prognosis and management, especially parenchyma-sparing surgery and medical targeted therapies such as mTOR, MEK and HIF-2 \u03b1 inhibitors, which have shown truly encouraging results.<\/jats:p>","DOI":"10.3389\/fendo.2021.678869","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T05:37:24Z","timestamp":1620279444000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Phakomatoses and Endocrine Gland Tumors: Noteworthy and (Not so) Rare Associations"],"prefix":"10.3389","volume":"12","author":[{"given":"Benjamin","family":"Chevalier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hippolyte","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Jannin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madleen","family":"Lemaitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Do Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Cardot-Bauters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Espiard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Christine","family":"Vantyghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,6]]},"reference":[{"key":"B1","first-page":"1","article-title":"Chapter 121 - The Phakomatoses","volume-title":"Emery and Rimoin\u2019s Principles and Practice of Medical Genetics","author":"Huson","year":"2008"},{"key":"B2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K\u2013AKT Network At the Interface of Oncogenic Signalling and Cancer Metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00965","article-title":"RAS: Striking At the Core of the Oncogenic Circuitry","volume":"9","author":"Gimple","year":"2019","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2017.06.009","article-title":"RAS Proteins and Their Regulators in Human Disease","volume":"170","author":"Simanshu","year":"2017","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.02.004","article-title":"TOR Signaling in Growth, Metabolism, and Disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/ng1494","article-title":"Dysregulation of the TSC-mTOR Pathway in Human Disease","volume":"37","author":"Inoki","year":"2005","journal-title":"Nat Genet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.21.9658","article-title":"Identification of the Neurofibromatosis Type 1 Gene Product","volume":"88","author":"Gutmann","year":"1991","journal-title":"Proc Natl Acad Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-4058","article-title":"Proteomic Analysis Reveals Hyperactivation of the Mammalian Target of Rapamycin Pathway in Neurofibromatosis 1\u2013Associated Human and Mouse Brain Tumors","volume":"65","author":"Dasgupta","year":"2005","journal-title":"Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1 Tumor Suppressor Critically Regulates TSC2 and Mtor","volume":"102","author":"Johannessen","year":"2005","journal-title":"PNAS"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"Von Hippel-Lindau Disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/science.8493574","article-title":"Identification of the Von Hippel-Lindau Disease Tumor Suppressor Gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrc3844","article-title":"VHL, the Story of a Tumour Suppressor Gene","volume":"15","author":"Gossage","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.semcancer.2012.05.005","article-title":"Von Hippel\u2013Lindau: How a Rare Disease Illuminates Cancer Biology","volume":"23","author":"Richard","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and Characterization of the Tuberous Sclerosis Gene on Chromosome 16","volume":"75","year":"1993","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/ng0992-37","article-title":"Linkage of an Important Gene Locus for Tuberous Sclerosis to a Chromosome 16 Marker for Polycystic Kidney Disease","volume":"2","author":"Kandt","year":"1992","journal-title":"Nat Genet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/ng0597-64","article-title":"Germline Mutations of the PTEN Gene in Cowden Disease, an Inherited Breast and Thyroid Cancer Syndrome","volume":"16","author":"Liaw","year":"1997","journal-title":"Nat Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"17004","DOI":"10.1038\/nrdp.2017.4","article-title":"Neurofibromatosis Type 1","volume":"3","author":"Gutmann","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1988.00520290115023","article-title":"National Institutes of Health Consensus Development Conference, Neurofibromatosis: Conference Statement","volume":"45","year":"1988","journal-title":"Arch Neurol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2010.02.002","article-title":"Endocrine Tumours in Neurofibromatosis Type 1, Tuberous Sclerosis and Related Syndromes","volume":"24","author":"Lodish","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1086\/302726","article-title":"Mosaicism in Von Hippel\u2013Lindau Disease: Lessons From Kindreds With Germline Mutations Identified in Offspring With Mosaic Parents","volume":"66","author":"Sgambati","year":"2000","journal-title":"Am J Hum Genet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2019.01.005","article-title":"Optimization of Next-Generation Sequencing Technologies for Von Hippel Lindau (VHL) Mosaic Mutation Detection and Development of Confirmation Methods","volume":"21","author":"Coppin","year":"2019","journal-title":"J Mol Diagn"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1677\/ERC-08-0142","article-title":"Are Neuroendocrine Tumours a Feature of Tuberous Sclerosis? A Systematic Review","volume":"16","author":"Dworakowska","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.37.11.828","article-title":"Will the Real Cowden Syndrome Please Stand Up: Revised Diagnostic Criteria","volume":"37","author":"Eng","year":"2000","journal-title":"J Med Genet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1616","article-title":"Incidence and Clinical Characteristics of Thyroid Cancer in Prospective Series of Individuals With Cowden and Cowden-Like Syndrome Characterized by Germline PTEN, SDH, or KLLN Alterations","volume":"12","author":"Ngeow","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fendo.2012.00061","article-title":"Familial Follicular Cell-Derived Thyroid Carcinoma","volume":"3","author":"Son","year":"2012","journal-title":"Front Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2012-101339","article-title":"High Cumulative Risks of Cancer in Patients With PTEN Hamartoma Tumour Syndrome","volume":"50","author":"Bubien","year":"2013","journal-title":"J Med Genet"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1159\/000506422","article-title":"Occurrence and Natural History of Thyroid Cancer in Patients With Cowden Syndrome","volume":"9","author":"Szabo Yamashita","year":"2020","journal-title":"Eur Thyroid J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00515","article-title":"Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging","volume":"9","author":"Alrezk","year":"2018","journal-title":"Front Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/er.2017-00062","article-title":"New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification","volume":"38","author":"Crona","year":"2017","journal-title":"Endocr Rev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-00992","article-title":"Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years","volume":"102","author":"Hamidi","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","article-title":"Mutations in the SDHB Gene Are Associated With Extra-adrenal and\/or Malignant Phaeochromocytomas","volume":"63","author":"Gimenez-Roqueplo","year":"2003","journal-title":"Cancer Res"},{"key":"B33","first-page":"69","article-title":"Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing","volume":"38","author":"Eisenhofer","year":"2017","journal-title":"Clin Biochem Rev"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2004.045484","article-title":"Pheochromocytoma Catecholamine Phenotypes and Prediction of Tumor Size and Location by Use of Plasma Free Metanephrines","volume":"51","author":"Eisenhofer","year":"2005","journal-title":"Clin Chem"},{"key":"B35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF01607135","article-title":"Catecholamine Synthesizing Enzymes in 70 Cases of Functioning and non-Functioning Phaeochromocytoma and Extra-Adrenal Paraganglioma","volume":"421","author":"Kimura","year":"1992","journal-title":"Vichows Arch A Pathol Anat"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0077","article-title":"Plasma Methoxytyramine: Clinical Utility With Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma","volume":"177","author":"Rao","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.17925\/EE.2019.15.2.95","article-title":"Clinical Presentation and Outcomes of Phaeochromocytomas\/Paragangliomas in Neurofibromatosis Type 1","volume":"15","author":"Al-Sharefi","year":"2019","journal-title":"Eur Endocrinol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13163","article-title":"Pheochromocytoma and Paraganglioma in Patients With Neurofibromatosis Type 1","volume":"86","author":"Gruber","year":"2017","journal-title":"Clin Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)68171-2","article-title":"Von Recklingausen\u2019s Disease and Pheochromocytomas","volume":"162","author":"Walther","year":"2006","journal-title":"J Urol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1477-7819-8-14","article-title":"Pheochromocytoma Associated With Neurofibromatosis Type 1: Concepts and Current Trends","volume":"8","author":"Zografos","year":"2010","journal-title":"World J Surg Oncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-004-6128-y","article-title":"Pheochromocytoma in Von Hippel\u2013Lindau Disease and Neurofibromatosis Type 1","volume":"4","author":"Opocher","year":"2005","journal-title":"Fam Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc066006","article-title":"Clinical and Genetic Characteristics of Patients With Neurofibromatosis Type 1 and Pheochromocytoma","volume":"354","author":"Bausch","year":"2006","journal-title":"N Engl J Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2833","article-title":"Germline NF1 Mutational Spectra and Loss-of-Heterozygosity Analyses in Patients With Pheochromocytoma and Neurofibromatosis Type 1","volume":"92","author":"Bausch","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13265","article-title":"Pheochromocytomas are Diagnosed Incidentally and At Older Age in Neurofibromatosis Type 1","volume":"86","author":"Moramarco","year":"2017","journal-title":"Clin Endocrinol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/BF02915454","article-title":"Adrenal and Retroperitoneal Mixed Neuroendocrine-Neural Tumors","volume":"2","author":"Kimura","year":"1991","journal-title":"Endocr Pathol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1385\/IJGC:29:2:093","article-title":"Neurofibromatosis-1 and Ampullary Gangliocytic Paraganglioma Causing Biliary and Pancreatic Obstruction","volume":"29","author":"Castoldi","year":"2001","journal-title":"Int J Pancreatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00291","article-title":"Diagnosis, Pathological Findings, and Clinical Management of Gangliocytic Paraganglioma: A Systematic Review","volume":"8","author":"Okubo","year":"2018","journal-title":"Front Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04398-1","article-title":"European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for Radionuclide Imaging of Phaeochromocytoma and Paraganglioma","volume":"46","author":"Ta\u00efeb","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-019-05299-y","article-title":"Clinical and Biochemical Features of Pheochromocytoma Characteristic of Von Hippel\u2013Lindau Syndrome","volume":"44","author":"Li","year":"2020","journal-title":"World J Surg"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3045","article-title":"Pheochromocytoma Screening Initiation and Frequency in Von Hippel-Lindau Syndrome","volume":"100","author":"Aufforth","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14222","article-title":"Bilateral Pheochromocytoma: Clinical Characteristics, Treatment and Longitudinal Follow-Up","volume":"3","author":"Kittah","year":"2020","journal-title":"Clin Endocrinol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-00225","article-title":"New Insights Into Pheochromocytoma Surveillance of Young Patients With VHL Missense Mutations","volume":"3","author":"Fagundes","year":"2019","journal-title":"J Endocr Soc"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma","volume":"23","author":"Letouz\u00e9","year":"2013","journal-title":"Cancer Cell"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2626","article-title":"Clinical Utility of Functional Imaging With 18F-FDOPA in Von Hippel-Lindau Syndrome","volume":"97","author":"Weisbrod","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2018.11.023","article-title":"The Utility of 68Gallium-DOTATATE PET\/CT in the Detection of Von Hippel-Lindau Disease Associated Tumors","volume":"112","author":"Shell","year":"2019","journal-title":"Eur J Radiol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002438","article-title":"Genetics, Diagnosis, Management and Future Directions of Research of Phaeochromocytoma and Paraganglioma: A Position Statement and Consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Lenders","year":"2020","journal-title":"J Hypertens"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1306294","article-title":"High Incidence of Cardiovascular Complications in Pheochromocytoma","volume":"44","author":"Zelinka","year":"2012","journal-title":"Horm Metab Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.3390\/jcm9082435","article-title":"Cardiovascular Manifestations and Complications of Pheochromocytomas and Paragangliomas","volume":"9","author":"Y-Hassan","year":"2020","journal-title":"J Clin Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730110-00004","article-title":"Adverse Drug Reactions in Patients With Phaeochromocytoma","volume":"30","author":"Eisenhofer","year":"2007","journal-title":"Drug Saf"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10744","article-title":"Extent of Surgery for Phaeochromocytomas in the Genomic Era","volume":"105","author":"Rossitti","year":"2018","journal-title":"Br J Surg"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.1999.00974.x","article-title":"Adrenal-Sparing Surgery for Phaeochromocytoma","volume":"86","author":"Neumann","year":"1999","journal-title":"Br J Surg"},{"key":"B63","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1530\/EJE-15-0549","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: Outcome of Adrenal Sparing Surgery in Heritable Pheochromocytoma","volume":"174","author":"Castinetti","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0550","article-title":"Normal Overall Mortality Rate in Addison\u2019s Disease, But Young Patients are At Risk of Premature Death","volume":"160","author":"Erichsen","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0023","article-title":"Psychological Morbidity and Impaired Quality of Life in Patients With Stable Treatment for Primary Adrenal Insufficiency: Cross-Sectional Study and Review of the Literature","volume":"171","author":"Tiemensma","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2003.08.005","article-title":"Critical Size of Residual Adrenal Tissue and Recovery From Impaired Early Postoperative Adrenocortical Function After Subtotal Bilateral Adrenalectomy","volume":"134","author":"Brauckhoff","year":"2003","journal-title":"Surgery"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.586795","article-title":"Preoperative Management of Pheochromocytoma and Paraganglioma","volume":"11","author":"Fang","year":"2020","journal-title":"Front Endocrinol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2010.02181.x","article-title":"A Case of Using Cortical Sparing Adrenalectomy to Manage Bilateral Phaeochromocytoma in Neurofibromatosis Type 1","volume":"40","author":"Ku","year":"2010","journal-title":"Internal Med J"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.06.102","article-title":"Functional and Oncologic Outcomes of Partial Adrenalectomy for Pheochromocytoma in Patients With Von Hippel-Lindau Syndrome After At Least 5 Years of Followup","volume":"184","author":"Benhammou","year":"2010","journal-title":"J Urol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e198898","DOI":"10.1001\/jamanetworkopen.2019.8898","article-title":"Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing Adrenalectomy","volume":"2","author":"Neumann","year":"2019","journal-title":"JAMA Netw Open"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2012.07.003","article-title":"Partial Adrenalectomy Minimizes the Need for Long-Term Hormone Replacement in Pediatric Patients With Pheochromocytoma and Von Hippel-Lindau Syndrome","volume":"47","author":"Volkin","year":"2012","journal-title":"J Pediatr Surg"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.08.2099","article-title":"Adrenocortical Carcinomas and Malignant Phaeochromocytomas: ESMO\u2013EURACAN Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up","volume":"31","author":"Fassnacht","year":"2020","journal-title":"Ann Oncol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.890181","article-title":"Combination Chemotherapy Regimen in a Patient With Metastatic Malignant Pheochromocytoma and Neurofibromatosis Type 1","volume":"15","author":"Otoukesh","year":"2014","journal-title":"Am J Case Rep"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1972","article-title":"Use of the Tyrosine Kinase Inhibitor Sunitinib in a Patient With Von Hippel-Lindau Disease: Targeting Angiogenic Factors in Pheochromocytoma and Other Von Hippel-Lindau Disease-Related Tumors","volume":"94","author":"Jimenez","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e20190660","DOI":"10.1542\/peds.2019-0660","article-title":"Health Supervision for Children With Neurofibromatosis Type 1","volume":"143","author":"Miller","year":"2019","journal-title":"Pediatrics"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2018.28","article-title":"Care of Adults With Neurofibromatosis Type 1: A Clinical Practice Resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"20","author":"Stewart","year":"2018","journal-title":"Genet Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13023-020-1310-3","article-title":"Neurofibromatosis 1 French National Guidelines Based on an Extensive Literature Review Since 1966","volume":"15","author":"France Network","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70063-8","article-title":"Neurofibromatosis Type 1: A Multidisciplinary Approach to Care","volume":"13","author":"Hirbe","year":"2014","journal-title":"Lancet Neurol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2006.045906","article-title":"Guidelines for the Diagnosis and Management of Individuals With Neurofibromatosis 1","volume":"44","author":"Ferner","year":"2006","journal-title":"J Med Genet"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.4158\/EP13417.OR","article-title":"Pheochromocytoma in Neurofibromatosis Type 1: When Should it Be Suspected","volume":"20","author":"Shinall","year":"2014","journal-title":"Endocr Pract"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0233","article-title":"Interest of Systematic Screening of Pheochromocytoma in Patients With Neurofibromatosis Type 1","volume":"175","author":"K\u00e9p\u00e9n\u00e9kian","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2020.03.011","article-title":"Acute Stress Cardiomyopathy: Heart of Pheochromocytoma","author":"Cornu","year":"2020","journal-title":"Ann Endocrinol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4266(18)31234-4","article-title":"Hereditary Pheochromocytoma and Paraganglioma: Screening and Follow-Up Strategies in Asymptomatic Mutation Carriers","volume":"79","author":"Vermalle","year":"2018","journal-title":"Ann Endocrinol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02411","article-title":"Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and\/or Pheochromocytoma","volume":"104","author":"Buffet","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B85","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S2213-8587(20)30363-6","article-title":"Maternal and Fetal Outcomes in Phaeochromocytoma and Pregnancy: A Multicentre Retrospective Cohort Study and Systematic Review of Literature","volume":"9","author":"Bancos","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0547","article-title":"Von Hippel\u2013Lindau and Hereditary Pheochromocytoma\/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood","volume":"23","author":"Rednam","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B87","first-page":"B4763","article-title":"Danish vHL Coordination Group. Von Hippel-Lindau disease (vHL). National Clinical Guideline for Diagnosis and Surveillance in Denmark","volume":"60","author":"Binderup","year":"2013","journal-title":"Dan Med J"},{"key":"B88","unstructured":"French Recommendations for Clinical Surveillance in Von Hippel Lindau2018"},{"key":"B89","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","article-title":"Gastroenteropancreatic Neuroendocrine Tumours","volume":"9","author":"Modlin","year":"2008","journal-title":"Lancet Oncol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41574-020-0391-3","article-title":"Neuroendocrine Neoplasia of the Gastrointestinal Tract Revisited: Towards Precision Medicine","volume":"16","author":"Rindi","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO Classification of Tumours of the Digestive System","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1111\/his.14172","article-title":"Why did They Change That? Practical Implications of the Evolving Classification of Neuroendocrine Tumours of the Gastrointestinal Tract","volume":"78","author":"Gill","year":"2021","journal-title":"Histopathology"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1159\/000151562","article-title":"Thirteen-Month Registration of Patients With Gastroenteropancreatic Endocrine Tumours in France","volume":"89","author":"Lombard-Bohas","year":"2009","journal-title":"Neuroendocrinology"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23549","article-title":"Prognostic Relevance of a Novel TNM Classification System for Upper Gastroenteropancreatic Neuroendocrine Tumors","volume":"113","author":"Pape","year":"2008","journal-title":"Cancer"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One Hundred Years After \u201cCarcinoid\u201d: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.annpat.2020.01.002","article-title":"Inherited Tumor Syndromes of Gastroenteropancreatic and Thoracic Neuroendocrine Neoplasms","volume":"40","author":"Couvelard","year":"2020","journal-title":"Ann Pathol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-009-1123-0","article-title":"Periampullary and Duodenal Neoplasms in Neurofibromatosis Type 1: Two Cases and an Updated 20-Year Review of the Literature Yielding 76 Cases","volume":"14","author":"Relles","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.2000.01016.x","article-title":"Duodenal Somatostatinoma: A Case Report and Review of 31 Cases With Special Reference to the Relationship Between Tumor Size and Metastasis","volume":"50","author":"Tanaka","year":"2000","journal-title":"Pathol Int"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1159\/000444803","article-title":"Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum: Analysis of 203 Cases","volume":"104","author":"Vanoli","year":"2017","journal-title":"Neuroendocrinology"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200511000-00012","article-title":"Obstructive Jaundice Secondary to Neuroendocrine Tumour in a Patient With Von Recklinghausen\u2019s Disease","volume":"17","author":"Samonakis","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.8965","article-title":"Somatostatinoma: Beyond Neurofibromatosis Type 1","volume":"4","author":"Sandru","year":"2020","journal-title":"Exp Ther Med"},{"key":"B103","doi-asserted-by":"publisher","first-page":"398","DOI":"10.12659\/AJCR.898472","article-title":"Zollinger-Ellison Syndrome Associated With Von Recklinghausen Disease: Case Report and Literature Review","volume":"17","author":"Alshikho","year":"2016","journal-title":"Am J Case Rep"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcs203","article-title":"Neurofibromatosis Type 1 and Pancreatic Islet Cell Tumours: An Association Which Should be Recognized","volume":"108","author":"Rogers","year":"2015","journal-title":"QJM"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/398570","article-title":"Gastrointestinal Stromal Tumors Associated With Neurofibromatosis 1: A Single Centre Experience and Systematic Review of the Literature Including 252 Cases","volume":"2013","author":"Salvi","year":"2013","journal-title":"Int J Surg Oncol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000159775.77912.15","article-title":"NF1-Associated Gastrointestinal Stromal Tumors Have Unique Clinical, Phenotypic, and Genotypic Characteristics","volume":"29","author":"Andersson","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.18143","article-title":"Pancreatic Involvement in Von Hippel\u2013Lindau Disease","volume":"119","author":"Hammel","year":"2000","journal-title":"Gastroenterology"},{"key":"B108","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/MPA.0b013e31815f394a","article-title":"Endocrine Pancreatic Tumors in Von Hippel-Lindau Disease: Clinical, Histological, and Genetic Features","volume":"37","author":"Corcos","year":"2008","journal-title":"Pancreas"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2007.09.012","article-title":"Clinical, Genetic and Radiographic Analysis of 108 Patients With Von Hippel-Lindau Disease (VHL) Manifested by Pancreatic Neuroendocrine Tumors (PNETs)","volume":"142","author":"Blansfield","year":"2007","journal-title":"Surgery"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-02434","article-title":"In Silico VHL Gene Mutation Analysis and Prognosis of Pancreatic Neuroendocrine Tumors in Von Hippel\u2013Lindau Disease","volume":"103","author":"Tirosh","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-18-0100","article-title":"Preventive Medicine of Von Hippel\u2013Lindau Disease-Associated Pancreatic Neuroendocrine Tumors","volume":"25","author":"Krauss","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-013-0794-1","article-title":"Pancreatic Involvement in Japanese Patients With Von Hippel-Lindau Disease: Results of a Nationwide Survey","volume":"49","author":"Igarashi","year":"2014","journal-title":"J Gastroenterol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa507","article-title":"The Clinical Features and Molecular Mechanisms of ACTH-secreting Pancreatic Neuroendocrine Tumors","volume":"105","author":"Zhang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2759","article-title":"Molecular Profiling of Pancreatic Neuroendocrine Tumors in Sporadic and Von Hippel-Lindau Patients","volume":"18","author":"Speisky","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31057","article-title":"Transcriptional Alterations in Hereditary and Sporadic Nonfunctioning Pancreatic Neuroendocrine Tumors According to Genotype","volume":"124","author":"Keutgen","year":"2018","journal-title":"Cancer"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-012-1847-0","article-title":"Pancreatic Lesions in Von Hippel\u2013Lindau Disease? A Systematic Review and Meta-synthesis of the Literature","volume":"16","author":"Charlesworth","year":"2012","journal-title":"J Gastrointest Surg"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1097\/01.mpa.0000240604.26312.e4","article-title":"Clinical Characteristics of Pancreatic Neuroendocrine Tumors in Japanese Patients With Von Hippel-Lindau Disease","volume":"33","author":"Yamasaki","year":"2006","journal-title":"Pancreas"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn351","article-title":"Pancreatic Neuroendocrine Tumors (PNETs): Incidence, Prognosis and Recent Trend Toward Improved Survival","volume":"19","author":"Halfdanarson","year":"2008","journal-title":"Ann Oncol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000000875","article-title":"Clinical Profile of Pancreatic Cystic Lesions in Von Hippel-Lindau Disease: A Series of 48 Patients Seen At a Tertiary Institution","volume":"46","author":"Sharma","year":"2017","journal-title":"Pancreas"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1159\/000472254","article-title":"ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers","volume":"105","author":"Oberg","year":"2017","journal-title":"Neuroendocrinology"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2013.10.025","article-title":"Assessment of Tumor Growth in Pancreatic Neuroendocrine Tumors in Von Hippel Lindau Syndrome","volume":"218","author":"Weisbrod","year":"2014","journal-title":"J Am Coll Surg"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00160","article-title":"Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms","volume":"40","author":"Mafficini","year":"2019","journal-title":"Endocr Rev"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2011.01805.x","article-title":"Pancreatic Neuroendocrine Tumors in Patients With Tuberous Sclerosis Complex","volume":"82","author":"Larson","year":"2012","journal-title":"Clin Genet"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-00051","article-title":"Pancreatic Neuroendocrine Tumor in a Young Child With Tuberous Sclerosis Complex 1","volume":"3","author":"Mehta","year":"2019","journal-title":"J Endocr Soc"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2013.05.006","article-title":"Insulinoma of Genetic Aetiology","volume":"74","author":"Borson-Chazot","year":"2013","journal-title":"Ann Endocrinol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0972","article-title":"GEP- NETS UPDATE: Genetics of Neuroendocrine Tumors","volume":"174","author":"Crona","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-017-9497-0","article-title":"Expanding the Spectrum of Colonic Manifestations in Tuberous Sclerosis: L-Cell Neuroendocrine Tumor Arising in the Background of Rectal Pecoma","volume":"29","author":"Kolin","year":"2018","journal-title":"Endocr Pathol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1159\/000443171","article-title":"Enets Consensus Guidelines Update for the Management of Patients With Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1136\/gut.42.6.792","article-title":"Use of the Somatostatin Analogue Octreotide to Localise and Manage Somatostatin-Producing Tumours","volume":"42","author":"Angeletti","year":"1998","journal-title":"Gut"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnz004","article-title":"Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms","volume":"41","author":"Hofland","year":"2020","journal-title":"Endocr Rev"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2007.01371.x","article-title":"Severe Hypoglycaemia After Long-Acting Octreotide in a Patient With an Unrecognized Malignant Insulinoma","volume":"37","author":"Healy","year":"2007","journal-title":"Internal Med J"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2013.07.001","article-title":"Malignant Insulinoma: Recommendations for Characterisation and Treatment","volume":"74","author":"Baudin","year":"2013","journal-title":"Ann Endocrinol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13503","article-title":"Pasireotide for the Treatment of Refractory Hypoglycaemia From Malignant Insulinoma","volume":"88","author":"Hendren","year":"2018","journal-title":"Clin Endocrinol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/annonc\/mdx078","article-title":"A Randomized, Open-Label, Phase 2 Study of Everolimus in Combination With Pasireotide LAR or Everolimus Alone in Advanced, Well-Differentiated, Progressive Pancreatic Neuroendocrine Tumors: COOPERATE-2 Trial","volume":"28","author":"Kulke","year":"2017","journal-title":"Ann Oncol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2020.02.011","article-title":"Digestive Neuroendocrine Neoplasms (NEN): French Intergroup Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)","volume":"5","author":"de Mestier","year":"2020","journal-title":"Dig Liver Dis"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.03.304","article-title":"Gastroenteropancreatic Neuroendocrine Neoplasms: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up","volume":"31","author":"Pavel","year":"2020","journal-title":"Ann Oncol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2020-0069","article-title":"The Use of MEK Inhibitors in Neurofibromatosis Type 1\u2013Associated Tumors and Management of Toxicities","volume":"7","author":"Klesse","year":"2020","journal-title":"Oncol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1605943","article-title":"Activity of Selumetinib in Neurofibromatosis Type 1\u2013Related Plexiform Neurofibromas","volume":"375","author":"Dombi","year":"2016","journal-title":"N Engl J Med"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/now282","article-title":"A Phase I Trial of the MEK Inhibitor Selumetinib (AZD6244) in Pediatric Patients With Recurrent or Refractory Low-Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study","volume":"19","author":"Banerjee","year":"2017","journal-title":"Neuro Oncol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30277-3","article-title":"Selumetinib in Paediatric Patients With BRAF-aberrant or Neurofibromatosis Type 1-Associated Recurrent, Refractory, or Progressive Low-Grade Glioma: A Multicentre, Phase 2 Trial","volume":"20","author":"Fangusaro","year":"2019","journal-title":"Lancet Oncol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912735","article-title":"Selumetinib in Children With Inoperable Plexiform Neurofibromas","volume":"382","author":"Gross","year":"2020","journal-title":"N Engl J Med"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000000856","article-title":"Long-Term Prognosis of Resected Pancreatic Neuroendocrine Tumors in Von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place","volume":"262","author":"de Mestier","year":"2015","journal-title":"Ann Surg"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1067\/msy.1998.91823","article-title":"Pancreatic Neuroendocrine Tumors Associated With Von Hippel Lindau Disease: Diagnostic and Management Recommendations","volume":"124","author":"Libutti","year":"1998","journal-title":"Surgery"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.37","article-title":"Evaluation and Management of Pancreatic Lesions in Patients With Von Hippel\u2013Lindau Disease","volume":"13","author":"Keutgen","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MPA.0000000000001454","article-title":"The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors","volume":"49","author":"Howe","year":"2020","journal-title":"Pancreas"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001778","article-title":"Risk Factors for New-Onset Diabetes Mellitus After Distal Pancreatectomy","volume":"8","author":"Dai","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B147","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jamcollsurg.2019.12.016","article-title":"Post-Pancreatectomy Diabetes Index: A Validated Score Predicting Diabetes Development After Major Pancreatectomy","volume":"230","author":"Maxwell","year":"2020","journal-title":"J Am Coll Surg"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002419","article-title":"Safety of Islet Autotransplantation After Pancreatectomy for Adenocarcinoma","volume":"103","author":"Renaud","year":"2019","journal-title":"Transplantation"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2018.07.006","article-title":"Indications for Islet or Pancreatic Transplantation: Statement of the TREPID Working Group on Behalf of the Soci\u00e9t\u00e9 Francophone Du Diab\u00e8te (SFD), Soci\u00e9t\u00e9 Francaise D\u2019endocrinologie (SFE), Soci\u00e9t\u00e9 Francophone De Transplantation (SFT) and Soci\u00e9t\u00e9 Fran\u00e7aise De N\u00e9phrologie \u2013 Dialyse \u2013 Transplantation (SFNDT)","volume":"45","author":"Wojtusciszyn","year":"2019","journal-title":"Diabetes Metab"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003825","article-title":"Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors","volume":"364","author":"Raymond","year":"2011","journal-title":"N Engl J Med"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr011","article-title":"Pilot Trial of Sunitinib Therapy in Patients With Von Hippel\u2013Lindau Disease","volume":"22","author":"Jonasch","year":"2011","journal-title":"Ann Oncol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01122","article-title":"The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel\u2013Lindau Disease: A Retrospective Study of 32 Patients","volume":"9","author":"Ma","year":"2019","journal-title":"Front Oncol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30487-X","article-title":"Pazopanib in Patients With Von Hippel-Lindau Disease: A Single-Arm, Single-Centre, Phase 2 Trial","volume":"19","author":"Jonasch","year":"2018","journal-title":"Lancet Oncol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1093-z","article-title":"Targeting the HIF2\u2013VEGF Axis in Renal Cell Carcinoma","volume":"26","author":"Choueiri","year":"2020","journal-title":"Nat Med"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.5003","article-title":"Phase II Study of the Oral HIF-2\u03b1 Inhibitor MK-6482 for Von Hippel-Lindau Disease\u2013Associated Renal Cell Carcinoma","volume":"38","author":"Jonasch","year":"2020","journal-title":"J Clin Oncol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1159\/000443167","article-title":"ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site","volume":"103","author":"Pavel","year":"2016","journal-title":"Neuroendocrinology"},{"key":"B157","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and Safety of Everolimus for Subependymal Giant Cell Astrocytomas Associated With Tuberous Sclerosis Complex (EXIST-1): A Multicentre, Randomised, Placebo-Controlled Phase 3 Trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for Angiomyolipoma Associated With Tuberous Sclerosis Complex or Sporadic Lymphangioleiomyomatosis (EXIST-2): A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2018180687","article-title":"Cumulative Radiation Exposures From CT Screening and Surveillance Strategies for Von Hippel-Lindau\u2013Associated Solid Pancreatic Tumors","volume":"290","author":"Tirosh","year":"2019","journal-title":"Radiology"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcy215","article-title":"The UK Guidelines for Management and Surveillance of Tuberous Sclerosis Complex","volume":"112","author":"Amin","year":"2019","journal-title":"QJM Int J Med"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-007-3484-x","article-title":"Water-Clear Cell Parathyroid Adenoma Causing Primary Hyperparathyroidism in a Patient With Neurofibromatosis Type 1: Report of a Case","volume":"37","author":"Kodama","year":"2007","journal-title":"Surg Today"},{"key":"B162","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4172\/2324-9110.1000170","article-title":"Parathyroid Carcinoma Coincident With Neurofibromatosis Type 1","volume":"5","author":"Hayashibara","year":"2018","journal-title":"J Clin Exp Oncol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2008.07.015","article-title":"Parathyroid Carcinoma and Neurofibromatosis","volume":"144","author":"Demirjian","year":"2008","journal-title":"Surgery"},{"key":"B164","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12957-015-0520-y","article-title":"A Case of Tuberous Sclerosis Complex With Concomitant Primary Hyperparathyroidism Due to Parathyroid Adenoma: A Case Report","volume":"13","author":"Shinzato","year":"2015","journal-title":"World J Surg Oncol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-18-0304","article-title":"Molecular Genetic Insights Into Sporadic Primary Hyperparathyroidism","volume":"2","author":"Brewer","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"B166","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jocd.2012.11.009","article-title":"Epidemiology of Primary Hyperparathyroidism","volume":"16","author":"Clarke","year":"2013","journal-title":"J Clin Densitom"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.endoen.2012.01.014","article-title":"Acromegaly and Type 1 Neurofibromatosis. Is Association of Both Conditions Due to Chance","volume":"60","author":"Checa Garrido","year":"2013","journal-title":"Endocrinol Nutr"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ19-0035","article-title":"Acromegaly Caused by a Somatotroph Adenoma in Patient With Neurofibromatosis Type 1","volume":"66","author":"Hozumi","year":"2019","journal-title":"Endocr J"},{"key":"B169","doi-asserted-by":"publisher","first-page":"bcr-2017-222411","DOI":"10.1136\/bcr-2017-222411","article-title":"Large Pituitary Gland With an Expanding Lesion in the Context of Neurofibromatosis 1","volume":"2017","author":"Hannah-Shmouni","year":"2017","journal-title":"BMJ Case Rep"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2018-0034","article-title":"Update on the Clinicopathology of Pituitary Adenomas","volume":"24","author":"Lim","year":"2018","journal-title":"Endocr Pract"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)70327-5","article-title":"Precocious Puberty in Two Children With Neurofibromatosis Type I in the Absence of Optic Chiasmal Glioma","volume":"130","author":"Zacharin","year":"1997","journal-title":"J Pediatr"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.38308","article-title":"Growth Hormone Excess in Children With Neurofibromatosis Type-1 and Optic Glioma","volume":"173","author":"Cambiaso","year":"2017","journal-title":"Am J Med Genet"},{"key":"B173","first-page":"10","article-title":"Subependymal Astrocytic Hamartomas in the Eker Rat Model of Tuberous Sclerosis","volume":"151","author":"Yeung","year":"1997","journal-title":"Am J Pathol"},{"key":"B174","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1203\/01.PDR.0000147727.78571.07","article-title":"Effects of Rapamycin in the Eker Rat Model of Tuberous Sclerosis Complex","volume":"57","author":"Kenerson","year":"2005","journal-title":"Pediatr Res"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-18-0086","article-title":"Silent Gonadotroph Pituitary Neuroendocrine Tumor in a Patient With Tuberous Sclerosis Complex: Evaluation of a Possible Molecular Link","volume":"2018","author":"Regazzo","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated Genomic Characterization of Papillary Thyroid Carcinoma","volume":"159","author":"Agrawal","year":"2014","journal-title":"Cell"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu749","article-title":"Characterization of the Mutational Landscape of Anaplastic Thyroid Cancer Via Whole-Exome Sequencing","volume":"24","author":"Kunstman","year":"2015","journal-title":"Hum Mol Genet"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.535","article-title":"Risk of Benign Tumours of Nervous System, and of Malignant Neoplasms, in People With Neurofibromatosis: Population-Based Record-Linkage Study","volume":"108","author":"Seminog","year":"2013","journal-title":"Br J Cancer"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7590","article-title":"A Novel Combination of Metachronous Primary Malignancies of the Thyroid and Breast in a Patient With Neurofibromatosis Type 1","volume":"12","author":"Findakly","year":"2020","journal-title":"Cureus"},{"key":"B180","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10014-006-0203-z","article-title":"Skull Metastasis From Papillary Thyroid Carcinoma Accompanied by Neurofibromatosis Type 1 and Pheochromocytoma: Report of a Case","volume":"23","author":"Hashiba","year":"2006","journal-title":"Brain Tumor Pathol"},{"key":"B181","doi-asserted-by":"publisher","first-page":"1543.e3","DOI":"10.1016\/j.ajem.2020.04.004","article-title":"Diagnosis of Neurofibromatosis Type 1 After Rupture of Aneurysm and Consequent Fatal Hemothorax","volume":"38","author":"Miyamoto","year":"2020","journal-title":"Am J Emergency Med"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2013.12.003","article-title":"Patient Affected by Neurofibromatosis Type 1 and Thyroid C-cell Hyperplasia Harboring Pathogenic Germ-Line Mutations in Both NF1 and RET Genes","volume":"536","author":"Ercolino","year":"2014","journal-title":"Gene"},{"key":"B183","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1034\/j.1600-0404.2002.01159.x","article-title":"Thyroid Gland Neurofibroma in a NF1 Patient: NF1 and Thyroid Gland","volume":"106","author":"Anagnostouli","year":"2002","journal-title":"Acta Neurol Scand"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-008-3946-9","article-title":"Neurofibroma Adjacent to the Thyroid Gland and a Thyroid Papillary Carcinoma in a Patient With Neurofibromatosis Type 1: Report of a Case","volume":"39","author":"Koksal","year":"2009","journal-title":"Surg Today"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1159\/000488706","article-title":"Thyroid Gland 18f-Fdg Uptake in Neurofibromatosis Type 1","volume":"7","author":"van Lierop","year":"2018","journal-title":"Eur Thyroid J"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14802","article-title":"Limitations and Benefits of FDG-PET\/CT in NF1 Patients With Nerve Sheath Tumors: A Cross-Sectional\/Longitudinal Study","volume":"3","author":"Nishida","year":"2021","journal-title":"Cancer Sci"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2015.00188","article-title":"The PI3K\/Akt Pathway in Tumors of Endocrine Tissues","volume":"6","author":"Robbins","year":"2016","journal-title":"Front Endocrinol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP84INGJUVTBME","article-title":"Thyroid Pathology Findings in Cowden Syndrome: A Clue for the Diagnosis of the PTEN Hamartoma Tumor Syndrome","volume":"144","author":"Cameselle-Teijeiro","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1501993","article-title":"Biologic and Clinical Perspectives on Thyroid Cancer","volume":"375","author":"Fagin","year":"2016","journal-title":"N Engl J Med"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2010.0226","article-title":"Thyroid Pathology in PTEN -Hamartoma Tumor Syndrome: Characteristic Findings of a Distinct Entity","volume":"21","author":"Laury","year":"2011","journal-title":"Thyroid"},{"key":"B191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients With Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"","journal-title":"Thyroid"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1002\/hed.22971","article-title":"Thyroid Disease Associated With Cowden Syndrome: A Meta-Analysis","volume":"35","author":"Hall","year":"2013","journal-title":"Head Neck"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2012.08.055","article-title":"Should Patients With Cowden Syndrome Undergo Prophylactic Thyroidectomy","volume":"152","author":"Milas","year":"2012","journal-title":"Surgery"},{"key":"B194","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1634\/theoncologist.2019-0514","article-title":"A Pilot Study of Sirolimus in Subjects With Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in PTEN","volume":"24","author":"Komiya","year":"2019","journal-title":"Oncologist"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-020-0651-7","article-title":"Cancer Surveillance Guideline for Individuals With PTEN Hamartoma Tumour Syndrome","volume":"28","author":"Tischkowitz","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1159\/000508872","article-title":"Recommendations on Surveillance for Differentiated Thyroid Carcinoma in Children With PTEN Hamartoma Tumor Syndrome","volume":"9","author":"Jonker","year":"2020","journal-title":"Eur Thyroid J"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.678869\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T05:37:37Z","timestamp":1620279457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.678869\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":196,"alternative-id":["10.3389\/fendo.2021.678869"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.678869","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,6]]},"article-number":"678869"}}